161 related articles for article (PubMed ID: 33859526)
1. Para-chloro-2-[
Silins I; Sundin A; Nordeman P; Jahan M; Estrada S; Monazzam A; Lubberink M; Aigbirhio F; Hellman P; Antoni G
Int J Med Sci; 2021; 18(10):2187-2196. PubMed ID: 33859526
[No Abstract] [Full Text] [Related]
2. Radiation dosimetry of para-chloro-2-[
Silins I; Moreno A; Wall A; Aigbirhio F; Gurnell M; Brown M; Roslin S; Antoni G; Hellman P; Sundin A; Lubberink M
EJNMMI Res; 2024 May; 14(1):48. PubMed ID: 38771379
[TBL] [Abstract][Full Text] [Related]
3. Development of [
Bongarzone S; Basagni F; Sementa T; Singh N; Gakpetor C; Faugeras V; Bordoloi J; Gee AD
Nucl Med Biol; 2019; 68-69():14-21. PubMed ID: 30578137
[TBL] [Abstract][Full Text] [Related]
4. First-in-human evaluation of [
Silins I; Sundin A; Lubberink M; O'Sullivan L; Gurnell M; Aigbirhio F; Brown M; Wall A; Åkerström T; Roslin S; Hellman P; Antoni G
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):398-409. PubMed ID: 36074157
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.
Zettinig G; Mitterhauser M; Wadsak W; Becherer A; Pirich C; Vierhapper H; Niederle B; Dudczak R; Kletter K
Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1224-30. PubMed ID: 15197504
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors.
Bergström M; Bonasera TA; Lu L; Bergström E; Backlin C; Juhlin C; Långström B
J Nucl Med; 1998 Jun; 39(6):982-9. PubMed ID: 9627330
[TBL] [Abstract][Full Text] [Related]
7. [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings.
Hennings J; Lindhe O; Bergström M; Långström B; Sundin A; Hellman P
J Clin Endocrinol Metab; 2006 Apr; 91(4):1410-4. PubMed ID: 16403816
[TBL] [Abstract][Full Text] [Related]
8. 11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism.
Hennings J; Sundin A; Hägg A; Hellman P
Langenbecks Arch Surg; 2010 Sep; 395(7):963-7. PubMed ID: 20644954
[TBL] [Abstract][Full Text] [Related]
9. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
Hennings J; Hellman P; Ahlström H; Sundin A
Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
[TBL] [Abstract][Full Text] [Related]
10. Functional imaging of adrenal cortex.
Prado-Wohlwend S;
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):393-404. PubMed ID: 33222841
[TBL] [Abstract][Full Text] [Related]
11. Automated radiosynthesis of [
Hird M; Russell JJ; Corrigan LL; Boros I; Nordeman P; Antoni G; Gurnell M; Aigbirhio FI
J Labelled Comp Radiopharm; 2024 Feb; 67(2):67-75. PubMed ID: 38116667
[TBL] [Abstract][Full Text] [Related]
12. 11C-metomidate PET imaging of adrenocortical cancer.
Khan TS; Sundin A; Juhlin C; Långström B; Bergström M; Eriksson B
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):403-10. PubMed ID: 12634969
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro evaluation of [18F]FETO with respect to the adrenocortical and GABAergic system in rats.
Mitterhauser M; Wadsak W; Wabnegger L; Sieghart W; Viernstein H; Kletter K; Dudczak R
Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1398-401. PubMed ID: 12845489
[TBL] [Abstract][Full Text] [Related]
14. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
Minn H; Salonen A; Friberg J; Roivainen A; Viljanen T; Långsjö J; Salmi J; Välimäki M; Någren K; Nuutila P
J Nucl Med; 2004 Jun; 45(6):972-9. PubMed ID: 15181132
[TBL] [Abstract][Full Text] [Related]
15. Predicting Treatment Response in Primary Aldosteronism Using 11 C-Metomidate Positron Emission Tomography.
Lu CC; Chen CJ; Peng KY; Chueh JS; Chang CC; Yen RF; Wu VC;
Clin Nucl Med; 2022 Nov; 47(11):936-942. PubMed ID: 36215396
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.
Burton TJ; Mackenzie IS; Balan K; Koo B; Bird N; Soloviev DV; Azizan EA; Aigbirhio F; Gurnell M; Brown MJ
J Clin Endocrinol Metab; 2012 Jan; 97(1):100-9. PubMed ID: 22112805
[TBL] [Abstract][Full Text] [Related]
17.
Chen Cardenas SM; Santhanam P
Endocrine; 2020 Dec; 70(3):479-487. PubMed ID: 32886316
[TBL] [Abstract][Full Text] [Related]
18. Masked volume wise Principal Component Analysis of small adrenocortical tumours in dynamic [11C]-metomidate Positron Emission Tomography.
Razifar P; Hennings J; Monazzam A; Hellman P; Långström B; Sundin A
BMC Med Imaging; 2009 Apr; 9():6. PubMed ID: 19386097
[TBL] [Abstract][Full Text] [Related]
19. A Novel CYP11B2-Specific Imaging Agent for Detection of Unilateral Subtypes of Primary Aldosteronism.
Abe T; Naruse M; Young WF; Kobashi N; Doi Y; Izawa A; Akama K; Okumura Y; Ikenaga M; Kimura H; Saji H; Mukai K; Matsumoto H
J Clin Endocrinol Metab; 2016 Mar; 101(3):1008-15. PubMed ID: 26756116
[TBL] [Abstract][Full Text] [Related]
20. Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism.
Soinio M; Luukkonen AK; Seppänen M; Kemppainen J; Seppänen J; Pienimäki JP; Leijon H; Vesterinen T; Arola J; Lantto E; Helin S; Tikkanen I; Metso S; Mirtti T; Heiskanen I; Norvio L; Tiikkainen M; Tikkanen T; Sane T; Välimäki M; Gomez-Sanchez CE; Pörsti I; Nuutila P; Nevalainen PI; Matikainen N
Eur J Endocrinol; 2020 Dec; 183(6):539-550. PubMed ID: 33055298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
